Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Medical Genetics

The Diagnostic Pathway: Tests and Reports

At a Glance

Beta-mannosidosis is diagnosed by combining urine findings with markedly reduced or absent beta-mannosidase activity and genetic testing that identifies two disease-causing MANBA variants. These results help distinguish it from alpha-mannosidosis.

Confirming a diagnosis of beta-mannosidosis requires a combination of specialized biochemical and genetic tests. Because this condition is so rare, your doctors likely used a “tiered” approach—starting with a broad screen of your child’s waste products and moving toward specific genetic confirmation [1][2].

Step 1: Biochemical Clues

The first clue often comes from a urine test. When the beta-mannosidase enzyme is missing, specific protein fragments called oligosaccharides cannot be fully broken down and are instead “dumped” into the urine [3].

  • What it looks for: This test searches for a specific sugar fragment known as a disaccharide (specifically one called Man(beta1-4)GlcNAc) [4][3].
  • The Technology: Modern labs may use a highly sensitive method called mass spectrometry (often labeled as LC-MS/MS) [2][5]. While older methods like “thin-layer chromatography” (TLC) exist, mass spectrometry is frequently used today [6].
  • The Profile: While an abnormal urine profile can be a strong clue, it is not always the first test ordered, patterns can overlap, and a “normal” result does not absolutely rule out beta-mannosidosis [5].

Step 2: The Enzyme Assay

If the urine screen is suggestive, or if the doctor starts here, the next step is to measure the activity of the enzyme itself. This is often called an enzyme assay [4].

  • How it works: Scientists take a sample of your child’s blood and isolate the leukocytes (white blood cells) [4][7]. They then measure how well the beta-mannosidase enzyme functions within those cells.
  • The Results: In children with this condition, the enzyme activity is typically markedly reduced or completely absent [8]. (Note: Enzyme test values and “normal” ranges vary widely between different laboratories, so numbers should not be compared across different hospitals).
  • The Control: To ensure the sample didn’t degrade during shipping, the lab will often measure a second, unrelated enzyme at the same time to make sure its activity is normal [9].

Step 3: Genetic Testing of the MANBA Gene

While enzyme tests provide strong evidence, a diagnosis is generally supported by molecular genetic testing to find the specific errors in the MANBA gene [10].

  • Two Mutations Required: Because this is an autosomal recessive condition, the test must identify two pathogenic or likely pathogenic variants in the MANBA gene—one inherited from each parent [8][10].
  • When Testing is Complex: A “Variant of Uncertain Significance” (VUS) does not automatically confirm disease; it requires expert interpretation. Sometimes, standard sequencing (reading the gene like a book) only finds one mutation. If this happens, your doctor may need to order a more detailed look called deletion/duplication analysis or copy-number variant (CNV) analysis [4]. This can find larger sections of “missing” or “extra” genetic code that standard tests might miss [4].

Beta vs. Alpha: A Critical Distinction

It is common for parents to find information about alpha-mannosidosis when searching for answers, but these are distinct diseases [10].

Feature Beta-Mannosidosis Alpha-Mannosidosis
Enzyme Missing beta-mannosidase [3] alpha-mannosidase [11]
Gene Involved MANBA [10] MAN2B1 [11]
Urine Markers Often simple disaccharides (2 sugars) [4] Often complex mannose-rich chains [12]

Distinguishing between the two is vital because the treatments and expected complications are different [10]. Your medical team uses the specific enzyme levels and genetic results to ensure your child is classified correctly, as urinary patterns can suggest a disorder but enzyme and molecular results establish the diagnosis [4].

Common questions in this guide

What tests are used to diagnose beta-mannosidosis?
Doctors usually combine a urine test for abnormal sugar fragments, a beta-mannosidase enzyme assay using white blood cells, and testing of the MANBA gene. A urine pattern can raise suspicion, but enzyme and genetic results are used to establish the diagnosis.
Can a normal urine test rule out beta-mannosidosis?
No. Urine patterns can overlap with other conditions, and a normal result does not completely exclude beta-mannosidosis. Your doctor may still recommend enzyme testing and MANBA analysis when clinical or other laboratory findings remain concerning.
What does a low beta-mannosidase enzyme result mean?
Markedly reduced or absent beta-mannosidase activity in white blood cells supports beta-mannosidosis. Results should be interpreted using the testing laboratory’s own reference range because values and normal ranges can differ between laboratories; a second enzyme may be checked to assess sample quality.
Why might parental testing be recommended for MANBA variants?
Beta-mannosidosis is autosomal recessive, so affected individuals typically have two pathogenic or likely pathogenic MANBA variants, one inherited from each parent. Testing parents can show whether the variants are on opposite copies of the gene and help clarify the result.
What does a VUS in MANBA mean?
A variant of uncertain significance, or VUS, is a gene change whose effect is not yet clear. It does not by itself confirm or exclude beta-mannosidosis, so specialists interpret it alongside enzyme results, clinical findings, and other genetic evidence.
What happens if genetic testing finds only one MANBA variant?
If sequencing finds only one relevant MANBA variant, the testing team may consider deletion and duplication or copy-number analysis. These methods can detect larger missing or extra sections of genetic material that routine sequencing may not identify.
How is beta-mannosidosis different from alpha-mannosidosis?
Beta-mannosidosis involves reduced or absent beta-mannosidase activity and changes in MANBA, whereas alpha-mannosidosis involves alpha-mannosidase and MAN2B1. Their urine markers can also differ, so enzyme and genetic results help doctors classify the condition correctly.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Beta-mannosidosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Can you explain my child's genetic report, specifically what it means if the variants are 'pathogenic' or 'variants of uncertain significance' (VUS)?
  2. 2.Do we need to perform parental testing to confirm that the two MANBA variants are inherited from opposite sides of the family?
  3. 3.If only one variant was found on initial MANBA gene sequencing, do we need 'deletion and duplication' testing to find a second hidden variant?
  4. 4.Can you confirm that both clinical findings and specific lab tests were used to distinguish this from alpha-mannosidosis?
  5. 5.Can I have a plain-language summary of the confirmed diagnostic results to share with my child's school and other specialists?

References

References (12)
  1. 1

    Expanding the Phenotype Spectrum of β-Mannosidosis.

    Martin Rios AM, Gibbs LH, Stepien KM, et al.

    Neurology. Genetics 2025; (11(6)):e200317 doi:10.1212/NXG.0000000000200317.

    PMID: 41235131
  2. 2

    UPLC-MS/MS Analysis of Urinary Free Oligosaccharides for Lysosomal Storage Diseases: Diagnosis and Potential Treatment Monitoring.

    Huang R, Cathey S, Pollard L, Wood T

    Clinical chemistry 2018; (64(12)):1772-1779 doi:10.1373/clinchem.2018.289645.

    PMID: 30201803
  3. 3

    The structure of mammalian β-mannosidase provides insight into β-mannosidosis and nystagmus.

    Gytz H, Liang J, Liang Y, et al.

    The FEBS journal 2019; (286(7)):1319-1331 doi:10.1111/febs.14731.

    PMID: 30552791
  4. 4

    β-Mannosidosis caused by a novel homozygous intragenic inverted duplication in MANBA.

    Blomqvist M, Smeland MF, Lindgren J, et al.

    Cold Spring Harbor molecular case studies 2019; (5(3)) doi:10.1101/mcs.a003954.

    PMID: 30886116
  5. 5

    A new UHPLC-MS/MS method for the screening of urinary oligosaccharides expands the detection of storage disorders.

    Semeraro M, Sacchetti E, Deodato F, et al.

    Orphanet journal of rare diseases 2021; (16(1)):24 doi:10.1186/s13023-020-01662-8.

    PMID: 33422100
  6. 6

    Development of a new tandem mass spectrometry method for urine and amniotic fluid screening of oligosaccharidoses.

    Piraud M, Pettazzoni M, Menegaut L, et al.

    Rapid communications in mass spectrometry : RCM 2017; (31(11)):951-963 doi:10.1002/rcm.7860.

    PMID: 28370531
  7. 7

    Biochemical and clinical response after umbilical cord blood transplant in a boy with early childhood-onset beta-mannosidosis.

    Lund TC, Miller WP, Eisengart JB, et al.

    Molecular genetics & genomic medicine 2019; (7(7)):e00712 doi:10.1002/mgg3.712.

    PMID: 31115173
  8. 8

    Familial Global Developmental Delay Secondary to β-Mannosidosis.

    Gowda VK, Nagarajan B, Suryanarayana SG, Srinivasan VM

    Journal of pediatric neurosciences 2021; (16(2)):149-152 doi:10.4103/jpn.JPN_65_20.

    PMID: 35018184
  9. 9

    Hereditary β-mannosidosis in a dog: Clinicopathological and molecular genetic characterization.

    Bolfa P, Wang P, Nair R, et al.

    Molecular genetics and metabolism 2019; (128(1-2)):137-143 doi:10.1016/j.ymgme.2019.08.002.

    PMID: 31439511
  10. 10

    Phenotype variability in six new patients with beta-mannosidosis.

    Olivas M, Romano C, Martin A, et al.

    Molecular genetics and metabolism 2026; (149(1-2)):110230 doi:10.1016/j.ymgme.2026.110230.

    PMID: 42600418
  11. 11

    Relationship between MAN2B1 genotype/subcellular localization subgroups, antidrug antibody detection, and long-term velmanase alfa treatment outcomes in patients with alpha-mannosidosis.

    Borgwardt LG, Ceravolo F, Zardi G, et al.

    JIMD reports 2023; (64(2)):187-198 doi:10.1002/jmd2.12349.

    PMID: 36873087
  12. 12

    Analysis of urinary oligosaccharide excretion patterns by UHPLC/HRAM mass spectrometry for screening of lysosomal storage disorders.

    Hagemeijer MC, van den Bosch JC, Bongaerts M, et al.

    Journal of inherited metabolic disease 2023; (46(2)):206-219 doi:10.1002/jimd.12597.

    PMID: 36752951

This page explains beta-mannosidosis diagnostic tests for informational purposes only and does not constitute medical advice. Ask your child’s medical genetics or metabolic care team to interpret the reports and discuss next steps.